West China Hospital clinical trials
Listed in the registry as: University, hospital or other organization.
The registry lists 498 studies whose lead sponsor is West China Hospital. 244 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 26, 2026.
Keep track of what changes. Save the West China Hospital studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesStatus
Where
- China
- 408
Focus areas
Conditions West China Hospital leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Colorectal Neoplasms20Head and Neck Neoplasms19Carcinoma18Carcinoma, Non-Small-Cell Lung17Squamous Cell Carcinoma of Head and Neck17Carcinoma, Hepatocellular14Rectal Neoplasms14Neoplasms12Stomach Neoplasms12Lung Neoplasms11Breast Neoplasms10Esophageal and Gastric Varices10Hypertension, Portal10Liver Cirrhosis10
Studies
Recruiting first, then most recently updated. Showing 50 of 498. Browse all 498 →
- A Study of Perioperative Adebrelimab Plus Chemotherapy Versus Adjuvant Therapy in Patients With Resectable NSCLCNot yet recruitingNCT07895238Phase 3
- Fruquintinib Combined With Capecitabine as Adjuvant Extended Therapy After R0 Resection and Perioperative Chemotherapy in Patients With Liver-Only Metastatic Colorectal CancerNot yet recruitingNCT07885384Phase 3
- Transvaginal Diverticulum Wall Filling and Coverage Technique for Treating Female Circumferential Urethral DiverticulumEnrolling by invitationNCT07006753Not applicable
- PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.RecruitingNCT07053072Phase 1
- Surgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular CarcinomaNot yet recruitingNCT07866612Not applicable
- CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACSRecruitingNCT07612774Phase 4
- Surgery vs. Watch-and-Wait Strategy in Partial & Complete Responders for Hepatocellular CarcinomaRecruitingNCT07410715
- Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung CancerRecruitingNCT07855965Phase 2
- SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBCRecruitingNCT06627712Phase 3
- Sirolimus Discontinuation Strategies in Kaposiform HemangioendotheliomaRecruitingNCT07131644Phase 2
- Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis ProgressionRecruitingNCT07715279Phase 2
- Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)RecruitingNCT07718126Phase 4
- Safety and Efficacy of Folic Acid Combined With Atezolizumab and Bevacizumab as First-Line Therapy for Unresectable Hepatocellular CarcinomaNot yet recruitingNCT07835737Phase 1/2
- Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCCRecruitingNCT07565740Phase 1
- Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile HemangiomaRecruitingNCT06798363Phase 2/3
- Au-TMP and Radiotherapy for Advanced Melanoma With Anti-PD-1 TherapyRecruitingNCT07562841Phase 1
- Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCCRecruitingNCT07572864Phase 2
- Educational Videos for Thyroid Surgery PatientNot yet recruitingNCT07823543Not applicable
- Tai Chi for Cancer-Related Fatigue During Radiotherapy in Patients With Head and Neck CancerRecruitingNCT07809776Not applicable
- A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell CarcinomaRecruitingNCT07381075Phase 2
- PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPCNot yet recruitingNCT07649421Phase 2
- The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent PlatformsRecruitingNCT07310056Not applicable
- Akkermansia Muciniphila (AKK) for Radiation-Induced Skin InjuryRecruitingNCT07635277Phase 1
- A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVIV Vaccine in Patients With Ovarian Cancer After SurgeryRecruitingNCT07676890Phase 1
- Safety and Efficacy of Canagliflozin in Patients With Locally Advanced or Advanced Solid CancerRecruitingNCT07703163Phase 1
- A Single-Arm, Open-Label, Prospective Study Evaluating the Safety, Tolerability, and Immunogenicity of the NeoOVSV Vaccine in Patients With Ovarian Cancer After SurgeryRecruitingNCT07724106Phase 1
- Wireless Wearable Home Prehabilitation for Older Adults With NSCLCRecruitingNCT07809763Not applicable
- MDT-Based Umbrella Decision Model for Geriatric Lung Cancer PatientsRecruitingNCT07509333Not applicable
- GnP Combined With SHR-1701 and Apatinib as First-Line Treatment for Locally Advanced or Metastatic PDACNot yet recruitingNCT07802184Phase 1/2
- Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung CancerRecruitingNCT07076836Not applicable
- Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck TumorsRecruitingNCT07625423Phase 1
- Rehabilitation With Wearable Monitors for Post-Lung Cancer SurgeryNot yet recruitingNCT07733492Not applicable
- Online Sharing for Head & Neck Cancer SupportRecruitingNCT07766226Not applicable
- Early Warning and Stratified Diagnosis of Postoperative Respiratory Failure Based on Ventilator Waveform Image FeaturesRecruitingNCT07799636
- Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer ResectionNot yet recruitingNCT07797075Not applicable
- The Effect of Perioperative Intravenous Lidocaine Infusion on Post-amputation Pain in Amputee PatientsNot yet recruitingNCT07783867Not applicable
- Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular DegenerationRecruitingNCT07776522Phase 2
- Personalized ctDNA Monitoring for Predicting Immunotherapy Outcomes in Advanced Non-Clear Cell Renal Cell CarcinomaNot yet recruitingNCT07776483
- JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment FailureNot yet recruitingNCT07175389Phase 1/2
- YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic MalignanciesRecruitingNCT07763301Phase 1
- Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Treatment of Rectal Cancer: A Randomized Controlled TrialNot yet recruitingNCT07755124Phase 1/2
- A Comparative Study of Delayed Endoscopic DTI and Autologous Flap Reconstruction Post-MastectomyNot yet recruitingNCT07602868
- Disitamab Vedotin Combined With Sintilimab and Multimodal Radiotherapy for HER2-Positive Advanced Gastric Cancer After Second-Line Treatment Failure: A Prospective, Single-Arm Phase II Clinical TrialNot yet recruitingNCT07490990Phase 2
- A Single-Arm Study of Sintilimab and Disitamab Vedotin for Locally Advanced Eyelid Sebaceous Gland CarcinomaNot yet recruitingNCT07740993Phase 2
- Iparomlimab and Tuvonralimab (QL1706) Plus Lenvatinib and Chemotherapy for Extrapulmonary Neuroendocrine CarcinomaNot yet recruitingNCT07738159Phase 2
- YMN-136 Vaccine for Patients With Liver Metastasis of Colorectal Cancer Progressing After Third-Line TreatmentRecruitingNCT07409805Phase 1
- Remote Versus On-Site Robotic Surgery for Hepatobiliary and Pancreatic ProceduresNot yet recruitingNCT07716423Not applicable
- Ipilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical TrialNot yet recruitingNCT07715565Phase 2
- H101 Plus TACE for r/m HNSCCRecruitingNCT07398664Phase 2
- Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck CancerNot yet recruitingNCT07704372Phase 2